Targeting Tumor Microenvironment for Cancer Therapy
Open accessThe DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Abstract
Cancer development is highly associated to the physiological state of the tumor microenvironment (TME). Despite the existing heterogeneity of tumors from the same or from different anatomical locations, common features can be found in the TME maturation of epithelial-derived tumors. Genetic alterations in tumor cells result in hyperplasia, uncontrolled growth, resistance to apoptosis, and metabolic shift towards anaerobic glycolysis (Warburg effect). These events create hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by TME cells are central players in all these events. The TME profile is preponderant on prognosis and impacts efficacy of anti-cancer therapies. Hence, a big effort has been made to develop new therapeutic strategies towards a more efficient targeting of TME. These efforts focus on: (i) therapeutic strategies targeting TME components, extending from conventional therapeutics, to combined therapies and nanomedicines; and (ii) the development of models that accurately resemble the TME for bench investigations, including tumor-tissue explants, “tumor on a chip” or multicellular tumor-spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Main properties of in vitro 2D and 3D culture systems [187,188]. CAF, Cancer-associated fibroblast; ECM, Extracellular matrix.](https://figures.cochat.ai/paper-figures/5beab1962bf5470fbdf9b87661e2bff6/targeting-tumor-microenvironment-for-cancer-therapy-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the microenvironment of healthy tissue, the TME has augmented deposition of proteins such as collagen and fibronectin, high cytokine levels, increased proportion of fibroblasts and immune cells, and is immunosuppressive [82,83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“agents that degrade and/or deconstruct the ECM should be used cautiously, as they may lead to the release of factors that promote tumor progression and induce metastasis [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Concerning the therapeutic outcome of such drugs, although they showed to improve patient survival, it has not been as great as expected, mostly related to the fact that patients stop responding or do not respond at all to these therapies, or even due to the side effects, for instance, the increased risk of arterial t…”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“While some tumors present few signals of inflammation, others show a high number of immune cells either at the periphery or infiltrated within the tumor [70,71].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 3×
“Epithelial tumors display common features that allow for the setting of hallmarks that define cancer progression [7,8].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“For this reason, tumors are frequently regarded as “wounds that never heal” [7,92].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Research works printed but not linked: 1
- Larson B. 3D cell culture: A review of current techniques BioTek 2015 6 1 10
Cited by
Items 701–800 of 1,000
Recent Advances in Supramolecular-Macrocycle-Based Nanomaterials in Cancer Treatment
Pan, Z., Zhao, X., Li, Q., Zhang, Z., & Liu, Y. (2023) · Molecules · doi:10.3390/molecules28031241 · Cited by 9
Xu, P., Cheng, C., Dong, S., Wang, T., Xie, J., & Li, P. (2023) · BMC Cancer · doi:10.1186/s12885-023-10597-9 · Cited by 10
Li, J., Cao, Y., Zhang, X., An, M., & Liu, Y. (2023) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000001030 · Cited by 9
Bouges, E., Segers, C., Leys, N., Lebeer, S., Zhang, J., & Mastroleo, F. (2023) · Cancers · doi:10.3390/cancers15245859 · Cited by 9
Khalid, J. P., Martin, T. M., Prathap, L., Nisargandha, M. A., Nisha, B., & Kumar, M. S. K. (2024) · Cureus · doi:10.7759/cureus.53949 · Cited by 9
Homogeneous Polyporus polysaccharide exerts anti-bladder cancer effects via autophagy induction
Luo, S., Huang, X., Li, S., Chen, Y., Zhang, X., & Zeng, X. Z. (2024) · Pharmaceutical Biology · doi:10.1080/13880209.2024.2316195 · Cited by 10
In situ characterization of the tumor microenvironment
Sadeghirad, H., Naei, V. Y., O'Byrne, K. J., Warkiani, M. E., & Kulasinghe, A. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103083 · Cited by 9
Drug-Resistant Epithelial Ovarian Cancer: Current and Future Perspectives
Mehrotra, M., Phadte, P., Shenoy, P. S., Chakraborty, S., Gupta, S., & Ray, P. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-58311-7_4 · Cited by 10
Challenges of enzyme therapy: Why two players are better than one
Cuoghi, S., Caraffi, R., Anderlini, A., Baraldi, C., Enzo, E., Vandelli, M. A., Tosi, G., Ruozi, B., Duskey, J. T., & Ottonelli, I. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1979 · Cited by 9
Amato, L., Rosa, C. D., Rosa, V. D., Hossein, H. H. S., Ariano, A., Franco, P., Nele, V., Capaldo, S., Guida, G. D., Sepe, F., et al. (2024) · Cancers · doi:10.3390/cancers16183151 · Cited by 9
A Four-Dimensional Organoid System to Visualize Cancer Cell Vascular Invasion
Yanagisawa, K., Konno, M., Liu, H., Irie, S., Mizushima, T., Mori, M., Doki, Y., Eguchi, H., Matsusaki, M., & Ishii, H. (2020) · Biology · doi:10.3390/biology9110361 · Cited by 11
Li, G., Zhu, X., & Liu, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.639059 · Cited by 9
Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy
Zhou, Y., Che, Y., Fu, Z., Zhang, H., & Wu, H.-Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.902378 · Cited by 10
Li, L., Liu, Z., Wang, H., Wang, L., Ru, G., & Wang, Y. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/5288075 · Cited by 9
Hypoxia as a signal for prison breakout in cancer
Redfern, A. D., Agarwal, V., & Thompson, E. W. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000577 · Cited by 11
Hall, R. C. W., Ayat, N. R., Qiao, P. L., Vaidya, A. M., Ma, D., Aminoshariae, A., Stojanov, I. J., & Lu, Z. (2020) · Molecular Imaging and Biology · doi:10.1007/s11307-020-01524-6 · Cited by 9
Wei, T., Song, J., Liang, K., Li, L., Mo, X., Huang, Z., Chen, G., Mao, N., & Yang, J. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03489-z · Cited by 12
Fang, L., Zhu, Z., Han, M., Li, S., Kong, X., & Yang, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117480 · Cited by 9
Li, M., 王婷婷, Zhang, Z., & Dongye, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1742855 · Cited by 20
Lu, Y., Huang, X., Liu, X., He, Y., Hu, Z., Xu, W., Cao, G., & He, W. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s294129 · Cited by 10
Wu, G. J., Ren, K., He, M., Xu, J., Li, Z. Q., Bo, D., & Xue, Q. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s337198 · Cited by 8
Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy
Yu, B., Shen, Y., Zhang, X., Ding, L., Meng, Z., Wang, X., Han, M., Guo, Y., & Wang, X. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091765 · Cited by 8
Cancer-associated fibroblasts in acute leukemia
Gu, L., Liao, P. H., & Liu, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1022979 · Cited by 9
Xu, S., Gao, X., Qiu, J., Hong, F., Gao, F., Wang, X., & Zhang, S. (2023) · Aging · doi:10.18632/aging.204529 · Cited by 9
Du, Y., Huang, L., Mao, L., Wu, X., & Miao, J. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-1243 · Cited by 8
Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments
Um‐e‐Kalsoom, Wang, S., Qu, J., & Liu, L. (2024) · Cancer Medicine · doi:10.1002/cam4.70155 · Cited by 8
Park, S. Y., Lee, D. G., Jo, A., Choi, H., Lee, J. E., Jeong, A. J., Leem, S.-H., Jun, W., Shim, S.-I., Ye, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53326-8 · Cited by 8
Harguindey, S., Alfarouk, K. O., Orozco, J. D. P., Fais, S., & Devesa, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207475 · Cited by 8
A Potential Role of Adhesion Molecules on Lung Metastasis Enhanced by Local Inflammation
Horiguchi, H., Tsujimoto, H., Shinomiya, N., MATSUMOTO, Y., Sugasawa, H., Yamori, T., Miyazaki, H., Saitoh, D., Kishi, Y., & Ueno, H. (2020) · Anticancer Research · doi:10.21873/anticanres.14637 · Cited by 8
Choi, W., Battistella, C., & Gianneschi, N. C. (2020) · Biomaterials Science · doi:10.1039/d0bm01713b · Cited by 8
McMahon, N. P., Solanki, A., Wang, L. G., Montaño, A. R., Jones, J. A., Samkoe, K. S., Tichauer, K. M., & Gibbs, S. L. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01589-x · Cited by 8
Tan, G., Wu, A., Li, Z., Chen, G., Wu, Y., Huang, S., Chen, X., & Li, G. (2021) · Translational Andrology and Urology · doi:10.21037/tau-21-560 · Cited by 8
Progress and Hurdles of Therapeutic Nanosystems against Cancer
Martín-Contreras, M., Navarro-Marchal, S. A., Peula-García, J. M., & Jódar‐Reyes, A. B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020388 · Cited by 11
Wang, W., Shen, H., Liu, Z., Chen, Y., Hou, L., & Ding, Y. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100592 · Cited by 10
Zhou, L., Fang, H., Guo, F., Yin, M., Long, H., & Weng, G. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24582 · Cited by 8
Mehata, A. K., Viswanadh, M. K., Solomon, V. R., & Muthu, M. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824476-0.00018-8 · Cited by 8
Yang, L.-K., Lin, C.-X., Li, S., Liang, J.-J., Xiao, L., Xie, G., Liu, H., & Liao, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1036402 · Cited by 8
Vascular Progenitor Cells: From Cancer to Tissue Repair
Barachini, S., Ghelardoni, S., & Madonna, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062399 · Cited by 8
Hsu, C.-Y., Yanagi, T., Maeda, T., Nishihara, H., Miyamoto, K., Kitamura, S., Tokuchi, K., & Ujiie, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-35811-3 · Cited by 11
Jorge, P. F., Goodwin, M. L., Renes, M. H., Nijsten, M. W., & Pamenter, M. E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.859820 · Cited by 9
Sinha, S., Hembram, K. C., & Chatterjee, S. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.01.001 · Cited by 8
Hu, Q., Zuo, X., Gu, X., Liu, L., Tang, Y., Niu, X., Shi, Y., & Li-ping, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-05435-w · Cited by 11
Targeting cuproptosis in liver cancer: Molecular mechanisms and therapeutic implications
Zhou, Y., Zhu, Y., Hao, M.-Y., Li, H., Han, H.-S., Li, Y., Si, W.-R., Jiang, Q., & Wu, D. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02150-9 · Cited by 7
Obeagu, E. I. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003719 · Cited by 7
Angeli, S., Neophytou, C., Charalambous, A., Voutouri, C., Themistokleous, P., Stylianopoulos, T., & Mpekris, F. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114546 · Cited by 9
Mattiussi, S., Herth, M. M., & Battisti, U. M. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118737 · Cited by 7
Gamal‐Eldeen, A. M., Raafat, B. M., Alrehaili, A. A., El‐Daly, S. M., Hawsawi, N. M., Banjer, H. J., Raafat, E. M., & Almehmadi, M. M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.854780 · Cited by 7
Circ_0024108 promotes the progression of esophageal cancer cells
Hu, T., Peng, H., Yang, F., Zhang, F., & He, J. (2023) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-023-01909-8 · Cited by 7
Suresh, P. K., Banerjee, A., & Singh, P. (2023) · OpenNano · doi:10.1016/j.onano.2023.100134 · Cited by 8
Patenaude, R. A., Yasmin‐Karim, S., Peng, Y., Wucherpfennig, K. W., Ngwa, W., Kheir, J. N., & Polizzotti, B. D. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.12.051 · Cited by 7
Jia-wen, W., Jinfu, W., Liu, J., Yaoguang, Z., & Wang, J. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04986-7 · Cited by 7
Wang, L., Shan, Y., Zheng, S., Li, J., & Cui, P. L. (2023) · Stem Cells International · doi:10.1155/2023/2759679 · Cited by 7
RetractedMASTRONIKOLIS, N. S., Spyropoulou, D., Kyrodimos, E., Piperigkou, Z., Giotakis, E. I., Delides, A., & Karamanos, N. K. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00337.2023 · Cited by 8
Advances and challenges in clinical applications of tumor cell-derived extracellular vesicles
Li, Y., Zeng, X., Hu, X., Wen, Q., & Chen, P. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113704 · Cited by 7
Chen, L., Huang, F., Luo, X., & Chen, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26852 · Cited by 7
Exosomal noncoding RNAs: decoding their role in thyroid cancer progression
Sun, W., Jiang, C., Liu, Q., Wang, N., Huang, R., Jiang, G., & Yang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1337226 · Cited by 8
Zhu, J., Zhu, X., Shi, C., Li, Q., Jiang, Y., Chen, X., Sun, P., Jin, Y., Wang, T., & Chen, J. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03457-4 · Cited by 8
Controlled Inflammation Drives Neutrophil‐Mediated Precision Drug Delivery in Heterogeneous Tumors
Guo, Y., Li, Y., Li, J., Cai, H., Liu, K., Duan, D., Zhang, W., Han, G., & Zhao, Y. (2025) · Advanced Science · doi:10.1002/advs.202411307 · Cited by 13
Liu, G., Liu, K., Ji, L., & Li, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-87194-2 · Cited by 7
Guan, X., Wu, D., Zhu, H., Zhu, B., Wang, Z., Xing, H., Zhang, X., Yan, J., Guo, Y., & Lu, Y. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214215 · Cited by 8
Targeting Cancer Stemness Using Nanotechnology in a Holistic Approach: A Narrative Review
Mitranovici, M.-I., Caravia, L. G., Moraru, L., & Pușcașiu, L. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030277 · Cited by 7
Zhang, Y., Hu, Y., Guo, H., Zhao, M., Liu, S., Liu, J., Huang, Y., & Wang, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-11799-w · Cited by 11
CAFs exosomal circFOXO1 promotes TNBC autophagy and radioresistance via miR-27a-3p/BNIP3 axis
Xun, X., Hu, H., Liu, Q., Su, R., & Ai, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-13876-6 · Cited by 9
Unveiling Tumor Microenvironment Interactions Using Zebrafish Models
Loveless, R., Shay, C., & Teng, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.611847 · Cited by 10
Advances in Engineered Biomaterials Targeting Angiogenesis and Cell Proliferation for Cancer Therapy
Yadav, P., Dua, C., & Bajaj, A. (2022) · The Chemical Record · doi:10.1002/tcr.202200152 · Cited by 7
Luo, Y., Zhou, L., Yang, F., Chen, J., Chen, J., & Wang, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-32620-6 · Cited by 8
Henn, J. G., Aguirre, T. A. S., Nugent, M., & Moura, D. J. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105254 · Cited by 11
Gardner, Z. S., Schumacher, T. J., Ronayne, C. T., Kumpati, G. P., Williams, M. J., Yoshimura, A., Palle, H., Mani, C., Rumbley, J. N., & Mereddy, V. R. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128136 · Cited by 8
The Use of Zebrafish Xenotransplant Assays to Analyze the Role of lncRNAs in Breast Cancer
Zampedri, C., Martínez-Flores, W. A., & Meléndez-Zajgla, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.687594 · Cited by 7
Gong, S., Wu, C., Duan, Y., Fu, J., Wang, Y., Wu, H., Zhang, B., Tang, J., & Wu, P. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13479 · Cited by 7
Immunological Role and Prognostic Potential of CLEC10A in Pan-CancerPreprint
Qin, Y., Zhang, L., Li, J., Liao, L., Huang, L., Li, W., & Yang, J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3932103 · Cited by 11
Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma
Wang, H., Li, Q., Tang, Q., Shi, G., Wu, G., Mao, X., Wu, C., Zhang, L., Liu, J., Li, J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1483721 · Cited by 10
IQGAP1: cross-disease target via receptor-pathway networks
Zhu, S., Zou, Y., Guo, J., Ma, W., Lu, L., Liu, R., Kang, J., Zhao, K., & Zhong, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1632060 · Cited by 6
Ma, J., Mei, W., Hu, H., Xu, Z., & Xu, Q. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01812a · Cited by 6
Cao, L., Ren, L., Yin, L., Xie, P., Qiu, G., Lü, T., Huang, X., Li, W., Wu, W., Zhang, K., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114694 · Cited by 6
Mirala, F., Kashkooli, F. M., & Soltani, M. (2026) · Microvascular Research · doi:10.1016/j.mvr.2026.104955 · Cited by 6
EPSTI1 as an immune biomarker predicts the prognosis of patients with stage III colon cancer
Wang, X., Cheng, W., Zeng, X., Dou, X., Zhou, Z., & Pei, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.987394 · Cited by 7
Mohan, N., Wellach, K., Özerdem, C., Veits, N., Förster, J. D., Föehr, S., Bonsack, M., & Riemer, A. B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918528 · Cited by 7
Ni, W., Yi, L., Dong, X., Cao, M., Zheng, J., Wei, Q., & Yuan, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-29316-2 · Cited by 8
Optimizing culturing conditions in patient derived 3D primary slice cultures of head and neck cancer
Greier, M. D. C., Runge, A., Dudás, J., Carpentari, L., Schartinger, V. H., Randhawa, A., Mayr, M., Petersson, M., & Riechelmann, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1145817 · Cited by 8
Liu, S., Zhai, J., Deng, L., Peng, Y., Wang, Y., & Dai, B. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21092 · Cited by 8
Exploring the landscape of drug resistance in gastrointestinal cancer immunotherapy: A review
Yao, N., Li, W., Duan, N., Xu, G., Yu, G., & Qu, J. (2024) · Medicine · doi:10.1097/md.0000000000036957 · Cited by 7
Perspectives on label-free microscopy of heterogeneous and dynamic biological systems
Pham, D. L., Gillette, A. A., Riendeau, J. M., Wiech, K. J., Guzman, E. C., Datta, R., & Skala, M. C. (2024) · Journal of Biomedical Optics · doi:10.1117/1.jbo.29.s2.s22702 · Cited by 11
Lin, Z., Xiao, S., Qi, Y., Guo, J., & Lu, L. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05803-5 · Cited by 6
Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments
Fattahi, A. S., Jafari, M., Farahavar, G., Abolmaali, S. S., & Tamaddon, A. M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104437 · Cited by 7
Ribeiro, J. H., Villarinho, N. J., Fernandes, P. V., Spohr, T. C. L. D. S. E., & Lopes, G. P. D. F. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30637 · Cited by 6
Tang, L., Wang, D., Hu, T., Lin, X., & Wu, S. (2024) · Cancer Drug Resistance · doi:10.20517/cdr.2024.77 · Cited by 14
Unlocking the Molecular Targets in Non-Small-Cell Lung Cancer and a Nanomedicine-Based Remedy
Sarma, K., Akhter, M. H., Alalmaie, A., Ahmad, I., Ansari, M. N., Khalilullah, H., Farhana, S. A., Hussain, S. M., & Aljadaan, A. M. (2025) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2024053289 · Cited by 6
Tang, Y., Wang, H., Zhang, J., Yang, C., Xu, F., Song, Y., Li, T., & Zhang, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-86185-7 · Cited by 7
Aqueous humor metabolomic profiling identifies a distinct signature in pseudoexfoliation syndrome
Zemītis, A., Vanags, J., Schiemer, T., Klavins, K., & Laganovska, G. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1487115 · Cited by 6
Wen, K. X., Wang, L., Su, H., Yu, L., Zhang, S., Wei, M., Wang, Y., Zhao, L., & Guo, Y. H. (2025) · BMC Cancer · doi:10.1186/s12885-025-13974-8 · Cited by 6
Singh, A., Pillai, L., Danes, D., Umar, S., & Balakrishnan, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10517-z · Cited by 6
Plant polysaccharides influence tumor development based on epigenetics: a review
Li, C., Hu, Y., & Yang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1588857 · Cited by 9
Feng, R., Cui, Z., Yang, L., & Liu, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-02588-6 · Cited by 6
Chiu, P.-C., Hsieh, P.-Y., Kang, J.-W., Chang, P., & Shen, L. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1669041 · Cited by 6
Technological challenges of theranostics in oncology
Das, S., & Das, M. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821712-2.00014-1 · Cited by 6
Peixoto, A., Cotton, S., Santos, L. L., & Ferreira, J. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_1 · Cited by 6
Zhang, Y., LIM, D. J., Cai, Z., Peng, J., Jia, B., Chu, G., Zhang, F., Dong, C., & Feng, Z. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113779 · Cited by 6
The cytotoxic effect of Baeckea frustescens extracts in eliminating hypoxic breast cancer cells
Shahruzaman, S. H., Yusof, F. Z. M., Maniam, S., Fakurazi, S., & Maniam, S. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03417-9 · Cited by 6
Metadata
- Authors
- Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R.
- Affiliations
- UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa. Campus de Caparica, 2829-516 Caparica, Portugal
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Baptista, Pedro V.
- Fernandes, Alexandra R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-15
- Volume
- 20
- Issue
- 4
- Pages
- 840
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6413095
- OpenAlex
- W2913062750
- Cited by
- 1,187
- References
- 212
- Citations by year
- 2026: 76 · 2025: 134 · 2024: 156 · 2023: 229 · 2022: 186 · 2021: 216 · 2020: 139 · 2019: 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/Multi/04378/2019, SFRH/BPD/124612/2016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, cancer therapy, Warburg effect, tumor hypoxia, oxidative stress, extracellular matrix, tumor stromal cells, tumor-associated macrophages, angiogenesis, metastasis, exosomes, nanomedicine, combination therapy, tumor models, tumor-on-a-chip, tumor spheroids
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Neovascularization, Pathologic, Nanomedicine, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.